Deep Gray Matter Involvement on Brain MRI Scans Is Associated with Clinical Progression in Multiple Sclerosis

Conventional brain MRI lesion measures have unreliable associations with clinical progression in multiple sclerosis (MS). Gray matter imaging may improve clinical‐MRI correlations.

[1]  W Craelius,et al.  Iron deposits surrounding multiple sclerosis plaques. , 1982, Archives of pathology & laboratory medicine.

[2]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[3]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[4]  S. LeVine,et al.  Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice , 1998, Journal of Neuroimmunology.

[5]  S. LeVine,et al.  Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.

[6]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[7]  Hompson,et al.  A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS , 2002 .

[8]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[9]  K. Zou,et al.  Quantitative analysis of MRI signal abnormalities of brain white matter with high reproducibility and accuracy , 2002, Journal of magnetic resonance imaging : JMRI.

[10]  J H Simon,et al.  Eight-year follow-up study of brain atrophy in patients with MS , 2002, Neurology.

[11]  J. Beard,et al.  Iron-deficient mice fail to develop autoimmune encephalomyelitis. , 2003, The Journal of nutrition.

[12]  S. LeVine,et al.  The Role of Iron in the Pathogenesis of Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 2004, Annals of the New York Academy of Sciences.

[13]  H. Schipper.  Heme Oxygenase‐1: Transducer of Pathological Brain Iron Sequestration under Oxidative Stress , 2004, Annals of the New York Academy of Sciences.

[14]  R. Henry,et al.  Measurement of Whole‐Brain Atrophy in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[15]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[16]  C. W. Tjoa,et al.  MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis , 2005, Journal of the Neurological Sciences.

[17]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[18]  Rohit Bakshi,et al.  Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. , 2005, Archives of neurology.

[19]  Susan A Gauthier,et al.  A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. , 2006, Autoimmunity reviews.

[20]  R. Bakshi,et al.  Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis , 2006, Multiple sclerosis.

[21]  Rohit Bakshi,et al.  The measurement and clinical relevance of brain atrophy in multiple sclerosis , 2006, The Lancet Neurology.

[22]  J. R. Mitchell,et al.  Deep grey matter `black T2` on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis , 2007, Multiple sclerosis.

[23]  Rohit Bakshi,et al.  Gray matter involvement in multiple sclerosis , 2007, Neurology.

[24]  S. LeVine,et al.  Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis , 2007, Multiple sclerosis.

[25]  J A Helpern,et al.  Quantitative Assessment of Iron Accumulation in the Deep Gray Matter of Multiple Sclerosis by Magnetic Field Correlation Imaging , 2007, American Journal of Neuroradiology.

[26]  R A Betensky,et al.  Predicting short-term disability in multiple sclerosis , 2007, Neurology.

[27]  R. Bakshi,et al.  T1‐ and T2‐Based MRI Measures of Diffuse Gray Matter and White Matter Damage in Patients with Multiple Sclerosis , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[28]  Rohit Bakshi,et al.  MRI in multiple sclerosis: current status and future prospects , 2008, The Lancet Neurology.

[29]  I. Pirko.  Erratum: Gray matter involvement in multiple sclerosis (Neurology (2007) 68 (634-642)) , 2008 .

[30]  Rohit Bakshi,et al.  MRI in multiple sclerosis: What’s inside the toolbox? , 2007, Neurotherapeutics.

[31]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.